- Zacks via Yahoo FinanceAug 12 11:40 AM
This compares to a loss per share of 15 cents a year ago. p> The Zacks Rank #4 (Sell) company's quarterly sales totaled $58.6 million, which beat the Zacks Consensus Estimate by 4.3%. On a year-over-year basis, revenues surged 35.8%.
- Zacks1 day ago
Global HIP Replacement Sales Market By Current Industry Status, Growth Opportunities, Top Key Players, Target Audience...Market Watch3 days ago
Orthopedic Power Tools Market 2019 Global Industry Share, Demand, Top Players, Industry Size, Future Growth By 2026Market Watch10 hours ago
- Zacks via Yahoo FinanceAug 02 15:38 PM
However, Enabling Technologies products revenues of $12 million in the quarter represented a 12.7% decline from the prior-year period. Cash Position Globus Medical exited the second quarter ...
- Zacks via Yahoo FinanceAug 02 13:15 PM
Revenues in Detail Revenues in the quarter totaled $572.6 million, beating the Zacks Consensus Estimate by 1.7%. Revenues fell 0.6% from the year-ago quarter (up 2.7% at constant currency or ...
- Zacks via Yahoo FinanceAug 09 12:54 PM
Pacific Biosciences of California, Inc. PACB incurred second-quarter 2019 adjusted loss of 16 cents per share, narrower than the Zacks Consensus Estimate of a loss of 18 cents. The company had incurred a loss of 17 cents in the year-ago quarter.
- Zacks via Yahoo FinanceAug 09 13:45 PM
The Zacks Rank #4 (Sell) company posted revenues of $93.6 million, outpacing the Zacks Consensus Estimate of $88 million. The figure also surpassed the company's expectations. However, revenues dropped 2.6% year over year.
- Zacks via Yahoo FinanceAug 05 13:08 PM
p style="text-align:justify;">Intersect ENT Inc. XENT reported second-quarter 2019 loss per share of 36 cents, wider than the Zacks Consensus Estimate of a loss of 34 cents. The reported loss ...
- Zacks via Yahoo FinanceAug 21 12:54 PM
Factors to Boost Stryker Stryker delivered second-quarter 2019 adjusted earnings per share (EPS) of $1.98, beating the Zacks Consensus Estimate by 2.6%. The bottom line improved ...
- Zacks via Yahoo FinanceAug 02 12:34 PM
Per management, internal sales growth was 3%.
- Zacks via Yahoo FinanceAug 06 12:58 PM
Adjusted EPS beat the Zacks Consensus Estimate by 1.2% on revenue growth across global Medical and Technology and Value-added Services businesses. p> On a reported basis, EPS from continuing ...
- Zacks via Yahoo FinanceAug 09 13:33 PM
Segmental Details Sales revenues amounted to $95.9 million in the quarter under review, up 4.2% on a year-over-year basis.